Sex, Age, and Tumor Genetics to Inform Risk Stratification in Papillary Thyroid Cancer - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Influence of Sex, Age, and Tumor Genetics on Risk Assessment in Papillary Thyroid Carcinoma

  • By

  • Carmelo Nucera

  • September 29, 2026

Share

Objective:

To investigate the prognostic relevance of sex, age, and tumor genetics in papillary thyroid carcinoma (PTC) and how these factors interact to influence disease-specific mortality.

Approach:
  • Study Design: A multinational investigation analyzing the impact of sex, age, and specific genetic mutations (BRAF V600E and TERT promoter mutations) on PTC outcomes.
Key Findings:
  • Male sex is associated with higher PTC-specific mortality, particularly in tumors with BRAF V600E or TERTp mutations.
  • The interaction between male sex and age significantly influences mortality risk, especially in men aged 45 years or older with both mutations.
  • Sex is not an independent prognostic factor in genetically wild-type tumors.
Limitations:
  • The retrospective nature of the study may introduce variability in treatment practices and molecular testing across different centers.
  • Differences in treatment protocols among participating institutions could affect outcomes.
Sources:

Original Source(s)

Related Content